PNEUMONIA is the #7 most commonly reported adverse reaction for CYCLOPHOSPHAMIDE, manufactured by Avyxa Pharma, LLC. There are 6,373 FDA adverse event reports linking CYCLOPHOSPHAMIDE to PNEUMONIA. This represents approximately 2.2% of all 284,202 adverse event reports for this drug.
Patients taking CYCLOPHOSPHAMIDE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PNEUMONIA6,373 of 284,202 reports
PNEUMONIA is a less commonly reported adverse event for CYCLOPHOSPHAMIDE, but still significant enough to appear in the safety profile.
Other Side Effects of CYCLOPHOSPHAMIDE
In addition to pneumonia, the following adverse reactions have been reported for CYCLOPHOSPHAMIDE:
PNEUMONIA has been reported as an adverse event in 6,373 FDA reports for CYCLOPHOSPHAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PNEUMONIA with CYCLOPHOSPHAMIDE?
PNEUMONIA accounts for approximately 2.2% of all adverse event reports for CYCLOPHOSPHAMIDE, making it a notable side effect.
What should I do if I experience PNEUMONIA while taking CYCLOPHOSPHAMIDE?
If you experience pneumonia while taking CYCLOPHOSPHAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.